ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
X4 Pharmaceuticals Inc

X4 Pharmaceuticals Inc (XFOR)

0.5921
-0.0711
(-10.72%)
終値: 11月13日 6:00AM
0.6164
0.0243
( 4.10% )
取引時間後: 7:59AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
0.6164
買値
0.605
売値
0.6165
出来高
2,239,878
0.59 日の範囲 0.68
0.4721 52 週間の範囲 1.60
時価総額
前日終値
0.6632
始値
0.67
最終取引時間
08:05:40
財務取引量
US$ 1,411,785
VWAP
0.630295
平均取引量 (3 か月)
1,068,134
発行済株式数
168,499,514
配当利回り
-
PER
-0.98
1 株当たり利益 (EPS)
-0.6
歳入
-
純利益
-101.17M

X4 Pharmaceuticals Inc について

X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad ra... X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme. 詳細を表示

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
X4 Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker XFOR. The last closing price for X4 Pharmaceuticals was US$0.66. Over the last year, X4 Pharmaceuticals shares have traded in a share price range of US$ 0.4721 to US$ 1.60.

X4 Pharmaceuticals currently has 168,499,514 shares in issue. The market capitalisation of X4 Pharmaceuticals is US$111.75 million. X4 Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.98.

XFOR 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.116423.280.50.67420.515459980.60422276CS
40.056410.07142857140.560.67420.4813535490.53768997CS
12-0.0755-10.91198150020.69190.7850.472110681340.59639468CS
26-0.4436-41.84905660381.061.130.472114714730.71960286CS
52-0.151-19.67683085740.76741.60.472120872280.91453573CS
156-4.1536-87.07756813424.775.090.472116182441.27239544CS
260-13.8836-95.748965517214.5150.472110115621.57527996CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MVSTMicrovast Holdings Inc
US$ 0.315
(74.32%)
8.01M
DAVEDave Inc
US$ 79.17
(26.07%)
44.66k
RKLBRocket Lab USA Inc
US$ 18.2291
(24.35%)
7.25M
CYCCCyclacel Pharmaceuticals Inc
US$ 0.5046
(23.07%)
2.65M
NMHINatures Miracle Holding Inc
US$ 0.1045
(21.94%)
6.27M
SYRSSyros Pharmaceuticals Inc
US$ 0.385
(-85.90%)
8.75M
VINOGaucho Group Holdings Inc
US$ 2.30
(-48.31%)
170.69k
VRMVroom Inc
US$ 5.25
(-40.81%)
45.79k
SIBNSI BONE Inc
US$ 11.50
(-26.42%)
4.79k
INSGInseego Corporation
US$ 13.69
(-24.61%)
36.45k
JGLOJP Morgan Global Select Equity ETF
US$ 63.13
(0.00%)
18.88M
SOUNSoundHound AI Inc
US$ 6.98
(-7.67%)
12.08M
LGMKLogicMark Inc
US$ 0.168
(-5.88%)
9.34M
SYRSSyros Pharmaceuticals Inc
US$ 0.385
(-85.90%)
8.77M
MVSTMicrovast Holdings Inc
US$ 0.315
(74.32%)
8.01M

XFOR Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock